Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725575) titled 'Efficacy of Intrathecal Administration of Budesonide to Prevent Bronchopulmonary Dysplasia' on July 21.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Investigator, Outcomes Assessor).

Primary Sponsor: Indonesia University

Condition: Bronchopulmonary Dysplasia (BPD)

Intervention: Drug: Experimental

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: November 1, 2024

Target Sample Size: 86

Countries of Recruitment: Indonesia

To know more, visit https://clinicaltrials.gov/study...